SOXF Transcription Factors
"SOXF Transcription Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of closely-related SOX transcription factors. Members of this subclass are expressed in VASCULAR ENDOTHELIAL CELLS and may play a role in vasculogenesis.
| Descriptor ID |
D055760
|
| MeSH Number(s) |
D12.776.260.719.600 D12.776.660.235.400.750.600 D12.776.664.235.400.750.600 D12.776.930.823.600
|
| Concept/Terms |
SOX18 Transcription Factor- SOX18 Transcription Factor
- Transcription Factor, SOX18
- SOX-18 Transcription Factor
- SOX 18 Transcription Factor
- Transcription Factor, SOX-18
SOX7 Transcription Factor- SOX7 Transcription Factor
- Transcription Factor, SOX7
- SOX-7 Transcription Factor
- SOX 7 Transcription Factor
- Transcription Factor, SOX-7
SOX17 Transcription Factor- SOX17 Transcription Factor
- Transcription Factor, SOX17
- SOX-17 Transcription Factor
- SOX 17 Transcription Factor
- Transcription Factor, SOX-17
|
Below are MeSH descriptors whose meaning is more general than "SOXF Transcription Factors".
Below are MeSH descriptors whose meaning is more specific than "SOXF Transcription Factors".
This graph shows the total number of publications written about "SOXF Transcription Factors" by people in this website by year, and whether "SOXF Transcription Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2018 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
| 2022 | 1 | 2 | 3 |
| 2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "SOXF Transcription Factors" by people in Profiles.
-
Response by Walters et al to Letter Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension". Circulation. 2023 11 28; 148(22):1825-1826.
-
SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension. Circulation. 2023 05 23; 147(21):1606-1621.
-
The SOX17 phenotype in pulmonary arterial hypertension: lessons for pathobiology and clinical management. Eur Respir J. 2022 12; 60(6).
-
An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis. Commun Biol. 2022 11 07; 5(1):1192.
-
A SOX17-PDGFB signaling axis regulates aortic root development. Nat Commun. 2022 07 13; 13(1):4065.
-
The pathophysiological role of novel pulmonary arterial hypertension gene SOX17. Eur Respir J. 2021 09; 58(3).
-
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis. Lancet Respir Med. 2019 03; 7(3):227-238.
-
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. Nat Commun. 2018 04 12; 9(1):1416.
-
Characterization of an in vitro differentiation assay for pancreatic-like cell development from murine embryonic stem cells: detailed gene expression analysis. Assay Drug Dev Technol. 2011 Aug; 9(4):403-19.